PROCEPT BioRobotics Corporation news

PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURP

REDWOOD CITY, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced positive five-year results from its 181 patient randomized WATER stu

Feb. 14, 2022

« Back Northside Healthcare System in Atlanta Advances Surgical Robotics Program with Multi-System, Multi-Hospital Agreement for PROCEPT BioRobotics AquaBeam Systems

First and only image-guided, heat-free surgical robotic procedure aims to establish a new standard of care for patients with enlarged prostates

REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advanc

Jan. 18, 2022